Navigation Links
NOVAVAX Reports Fourth Quarter and 2010 Year-End Financial Results
Date:3/28/2011

ification from U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA) that the Company's proposal to provide recombinant influenza vaccine products and manufacturing capabilities for pandemic preparedness was in the competitive range for award of an advanced development contract ($179 million contract award was announced subsequently in February 2011)
  • Reported positive clinical results from first-stage of 2009 H1N1 vaccine trial in Mexico (final results were presented in February 2011 at World Health Organization conference in Geneva)
  • Reported positive clinical results from Phase II seasonal influenza vaccine study in older adults
  • Completed construction and initiated validation testing of state-of-the-art vaccine production facility in India under the Company's joint venture with Cadila Pharmaceuticals
  • Received FDA clearance and initiated launch of a Phase I clinical trial in respiratory syncytial virus (RSV)
  • Published safety and efficacy findings from multiple pre-clinical studies supporting development of RSV vaccine based on virus-like particles
  • Received a key U.S. patent covering technology for rapid, efficient and uniform production of VLP-based vaccines against current and future strains of seasonal and pandemic influenza
  • Elected Stanley C. Erck as Executive Chairman of the Board of Directors and Richard H. Douglas, Ph.D. and James F. Young, Ph.D. as new Board of Director members
  • Awarded nearly $1 million in grants under the Internal Revenue Service's Therapeutic Discovery Project to support the development of VLP-based vaccines
  • Announced promotions of manufacturing managers and appointment of new Chief Medical Officer

  • Anticipated events in 2011:

  • Launch Phase II trial of seasonal influenza vaccine (under HHS BARDA contract)
  • Report top-line clinical data from Phase I RSV trial
  • Develop manuf
    '/>"/>

  • SOURCE Novavax, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
    2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
    3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
    4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
    5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
    6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
    7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
    8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
    9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
    10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
    11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... New York , August 20, 2014 ... a new market report titled "Monochloroacetic Acid (MCA) Market ... Applications - Global Industry Analysis, Size, Share, Growth, Trends ... market was valued at USD 817.1 million in 2013 ... 2020, growing at a CAGR of 3.6% during the ...
    (Date:8/20/2014)... , Aug. 20, 2014   Ventana Medical ...  Group, today announced that its VENTANA System for ... in the European Union for routine pathology, including ... consisting of VENTANA Virtuoso software coupled with either ... HT slide scanner, provides automated digital slide creation, ...
    (Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
    Breaking Medicine Technology:Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2
    ... RIDGEFIELD, Conn., Sept. 8 The country,s newest ... added the largest association of respiratory therapists - ... to its ranks.  The AARC joins DRIVE4COPD, the ... organizations the American Lung Association, COPD Foundation and ...
    ... (OTCQB: CGCP) today announced that the Wall Street ... McCormick.  The interview includes a discussion of the ... including an approximate 17% year-over-year increase in disposable ... and an overview of the company and its ...
    Cached Medicine Technology:American Association for Respiratory Care (AARC) Joins DRIVE4COPD to Raise Awareness of Nation's 4th Leading Cause of Death 2American Association for Respiratory Care (AARC) Joins DRIVE4COPD to Raise Awareness of Nation's 4th Leading Cause of Death 3American Association for Respiratory Care (AARC) Joins DRIVE4COPD to Raise Awareness of Nation's 4th Leading Cause of Death 4American Association for Respiratory Care (AARC) Joins DRIVE4COPD to Raise Awareness of Nation's 4th Leading Cause of Death 5Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online 2Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online 3
    (Date:8/20/2014)... 21, 2014 On September 7th, 2014 Peoria ... organization connects people living with MS with people who care. ... and are 85% of the way to their goal. This ... begins at 11:30 and the walk starts at 1:00 ... to answer question about chiropractic care and how it helps ...
    (Date:8/20/2014)... August 21, 2014 PAINWeek, the ... announced that Ethan Nadelmann, JD, PhD, will deliver ... is the founder and executive director of the ... United States promoting alternatives to the war on ... reform, both domestically and internationally, he has played ...
    (Date:8/20/2014)... Top10BestSEOHosting.com is a website dedicated to ... It is headed by a team of experts ... research-based information and factual studies about the newest ... market. , Recently, Top10BestSEOHosting.com has compared many ... and Bluehost are the most recommended suppliers ...
    (Date:8/20/2014)... Little Rock, AR (PRWEB) August 20, 2014 ... for providers to require a medical exam before issuing ... reports. The Quotes Pros company is now helping the ... medical exam through its system at http://quotespros.com/life-insurance.html . ... past two decades as more regulations have appeared in ...
    (Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... new experimental drug has saved a group of rhesus monkeys ... virus that kills up to 90 percent of those it ... with lethal doses of Marburg virus, even when it was ... Aug. 20 in the journal Science Translational Medicine . ...
    Breaking Medicine News(10 mins):Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2Health News:PAINWeek Welcomes Ethan Nadelmann, JD, PhD, as Keynote Speaker at 2014 Conference 2Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:Life Insurance Quotes Without Medical Exams Now Displayed to Adults at Insurance Website 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3
    ... the new program run by the Canadian MedicAlert Foundation.It ... and for procuring the special bracelet or necklet. ... medical problems such as allergies, asthma and diabetes in ... free. ,According to this foundation about five ...
    ... Researchers from Toronto, Canada have found that only a small ... not all the cells as believed earlier. // ,This ... have been found to be the source of the disease. ... This finding supports the view - stem cells may be ...
    ... the possibility that crucial infrastructure such as power and ... pandemic, biosecurity and health specialists have warned in the ... ,In a special influenza pandemic supplement, Mr ... for Immunisation Research and Surveillance of Vaccine Preventable Diseases, ...
    ... on a gene that could possibly be the reason behind ... taking a turn for the worse. // ,Melbourne scientist ... a gene known as body morphoygenic protein-4, (BMP4), was crucial ... the body. , ,The gene manufactures a protein ...
    ... animals have lost the ability to replace their missing limbs ... missing //leg with a brand new one that sprouts out ... Salk Institute for Biological Studies are successful in regenerating a ... to be able to regrow limbs. The study suggests ...
    ... Recent studies have dug out evidence that link cancer ... to the studies conducted by scientists from University of ... equator have lesser chances of contracting ovarian cancer. Their ... explains that more exposure of sunlight will result in ...
    Cached Medicine News:Health News:Cancer Stem Cells Alone spread Cancer 2Health News:Pandemic Planning for Hospitals 2Health News:Limb Regeneration Exists Innately In All Vertebrates – Says Researc 2Health News:Limb Regeneration Exists Innately In All Vertebrates – Says Researc 3
    MBP's equivalent to the "Universal Yellow" tip, this 200 ul tip utilizes a MicroPoint design for accurate sample handling. 10 L Ref. mark....
    ... easy way to order tips. Each box contains ... D10mL, which contains 200 tips (4 bags of ... Packs of 200 tips per pack. Bulk Packs ... easily be opened for quick access to Gilsons ...
    10 L, Bulk Recommended for 2, 5, 10 L pipettes....
    ... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
    Medicine Products: